Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-Month Analysis of the E-ZO-FAST Trial

Antonio Llombart‐Cussac, Patrick Neven, Outi Paija et al.|Clinical Breast Cancer|2011

Cited by 131